Zonisamide is a second-generation anticonvulsant approved for
use as an adjunctive therapy in adults with partial-onset seizures,
infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and
generalized tonic-clonic seizure. Zonisamide is marketed in the US under
the trade name Zonegran®.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Zonegran is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd.